Introduction
============

In addition to their use as a bridge-to-transplant, a bridge-to-recovery and as destination therapy, ventricular assist devices (VADs) are increasingly being used on patients \'in extremis\' as a salvage procedure, as a bridge to a long-term device. We performed a retrospective analysis of the clinical criteria for VAD insertion in patients who have received devices.

Methods
=======

Data were collected for all patients receiving a VAD in the last year, excluding those patients with a previous transplant or VAD. On each patient the following data were collected: age and degree of urgency of referral, diagnosis and duration of illness, pre-operative systems review within 24 hours of device insertion, device inserted, and outcome.

Results
=======

Fifteen patients were included. Three groups of five patients emerged based on the referral pattern and duration of illness. Group 1, emergency (less than 2 weeks illness) -- ischaemic and postpartum cardiomyopathy, acute myocardial infarction, myocarditis. Group 2, acute (less than 4 weeks illness) -- postpartum and dilated cardiomyopathy. Group 3, elective (assessed for transplantation) -- dilated and ischaemic cardiomyopathy. See Table [1](#T1){ref-type="table"}.

  --------------------------------------------------------------
                      Group 1      Group 2        Group 3
  ------------------- ------------ -------------- --------------
  Age (mean)          47.2         29.6           43.6

  CI (mean)           1.2          1.3            1.4

  LVEF (mean)         19%          16.6%          23.4%

  Inotropes           5/5          4/5            4/5

  IABP                1/5          0/5            1/5

  Ventilated          2/5          0/5            0/5

  Acidosis            5/5          0/5            0/5

  Renal dysfunction   4/5          1/5            3/5

  Liver dysfunction   4/5          3/5            5/5

  Device              Levitronix   Heartmate I\   Jarvik 2000\
                                   Jarvik 2000    Heartmate I\
                                                  Thoratec

  Survival            1/5          4/5            5/5
  --------------------------------------------------------------

Conclusion
==========

Once patients require inotropic support, early referral is preferred. Recent onset renal and liver dysfunction due to poor ventricular function will be improved with a VAD. The onset of a metabolic acidosis is a predictor of poor outcome but a salvage procedure is possible in most patients with acute ventricular dysfunction.
